Opinion
MDL 2724 16-MD-2724 16-CB-27242 16-CM-27242 16-PV-27242
05-10-2022
IN RE GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION THIS DOCUMENT RELATES TO: In re Clobetasol Cases (End-Payer) In re Clomipramine Cases (End-Payer) In re Pravastatin Cases (End-Payer)
ORDER
CYNTHIA M. RUFE, J.
AND NOW, this 10th day of May 2022, upon consideration of the Joint Motion to Dismiss [Doc. No. 186 in 16-CB-27242; Doc. No. 142 in 16-CB-27242; Doc. No. 173 in 16-PV-27242] and the responses and replies thereto, and for the reasons stated in the accompanying Memorandum Opinion, it is hereby ORDERED that the Motion is DENIED.
It is so ORDERED.